Drugs.com: Effect of cancer treatment on COVID-19 mortality

Cancer patients treated one to three months prior to COVID-19 diagnosis and those treated with chemoimmunotherapy have the highest 30-day mortality, according to a study presented at the annual meeting of the European Society for Medical Oncology, held virtually from Sept. 19 to 21.

Lead author Trisha Wise-Draper, MD, PhD, associate professor of medicine, UC Health oncologist and member of the UC Cancer Center, and colleagues examined outcomes related to systemic cancer treatment within one year of laboratory-confirmed severe acute respiratory syndrome coronavirus 2 infection.

Read the full Drugs.com/HealthDay News story.

Read the full UC News story.

Featured photo courtesy of the National Cancer Institute.

/University Release. The material in this public release comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.